(3-Methyl-4-oxo-3,4-dihydro-phthalazin-1-yl)-acetic acid, 95.0%, 1g

2,4-Dibromothiazole-5-carboxaldehyde, 95.0%, 10g

4-(4-Bromophenyl)-1-buten-4-ol, 96.0%, 1g

(S,E)-4-Bromo-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide (Afatinib Impurity), 98%, 50mg

Transfer membrane ROTI®NC 0.2, 300 × 30 cm, 1 Piece(s)

2-Bromo-1,1,1-trifluoro-3-methyl-butane, 1g

Tris(acetonitrile)cyclopentadienylruthenium(II) hexafluorophosphate, 98.0%, 5g

ACETIC ACID-1-13C, 95.0%, 1g

6-Formyl-2-methylsulfanyl-nicotinonitrile, 95.0%, 5g

O-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, 97.0%, 25g

1-Boc-3-N-(Pyridin-4-ylmethyl)-amino-pyrrolidine, 97.0%, 250mg

6-fluoro-2H-indazol-7-amine, 97%, 1g

7-Chloro-4-hydroxy-3-nitroquinoline, 95.0%, 1g